VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 229 filers reported holding VERACYTE INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,227,538 | -12.5% | 413,235 | -0.2% | 0.12% | -9.8% |
| Q2 2023 | $10,548,935 | +18.4% | 414,171 | +3.7% | 0.13% | +6.4% |
| Q1 2023 | $8,905,817 | -8.3% | 399,364 | -2.4% | 0.12% | -13.8% |
| Q4 2022 | $9,708,774 | +489.8% | 409,135 | +504.3% | 0.14% | +163.6% |
| Q1 2020 | $1,646,000 | -86.1% | 67,708 | -84.0% | 0.06% | -82.5% |
| Q4 2019 | $11,847,000 | +30.0% | 424,314 | +11.8% | 0.32% | +6.4% |
| Q3 2019 | $9,110,000 | -14.4% | 379,585 | +1.6% | 0.30% | -11.4% |
| Q2 2019 | $10,647,000 | +250.0% | 373,451 | +207.1% | 0.33% | +193.0% |
| Q1 2019 | $3,042,000 | +33.9% | 121,600 | -32.6% | 0.11% | +17.5% |
| Q4 2018 | $2,271,000 | +275.4% | 180,540 | +185.2% | 0.10% | +410.5% |
| Q3 2018 | $605,000 | -70.2% | 63,300 | -77.6% | 0.02% | -72.1% |
| Q4 2015 | $2,032,000 | +79.8% | 282,217 | +17.1% | 0.07% | +65.9% |
| Q3 2015 | $1,130,000 | – | 241,042 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |